Note: results can be filtered by year and/or keyword. To filter on year, select the appropriate year from the drop down menu. To filter on keyword, enter relevant term into open box, select appropriate keyword, and click "filter".
Reports
-
The Diagnosis and Treatment of Hepatitis C: A Technical Landscape
Opportunities to Revolutionise Care in Developing Countries This report provides an overview on the current state of play and a framework for action with regards to hepatitis C diagnostics and treatment in resource-poor settings.
Last updated 23 April 2013
www.msfaccess.org/content/diagnosis-and-treatment-hepatitis-c-technical-landscape -
Treating Buruli Ulcer: A Review of Prospects for Existing Antibiotics and New Therapeutics
Buruli ulcer disease is a serious necrotizing skin infection caused by the environmental pathogen Mycobacterium ulcerans and represents the third most common mycobacterial infection worldwide after tuberculosis and leprosy. This disease, if left untreated, can lead to disfiguring and disabling lesions, particularly affecting young populations in resource-poor settings.
Last updated 26 March 2013
www.msfaccess.org/content/treating-buruli-ulcer-review-prospects-existing-antibiotics-and-new-therapeutics -
Medical Innovation for Neglected Patients
Over the past half century, there have been unprecedented improvements in health outcomes, spurred in part by unparalleled scientific progress in the pharmaceutical sector. Yet access to the benefits of medical progress and scientific advancement has not been equitably shared and many innovation gaps remain. Three fundamental problems persist: 1. Global health needs are not in the driver's seat
Last updated 12 December 2012
www.msfaccess.org/content/medical-innovation-neglected-patients -
DR-TB Drugs Under the Microscope: 2nd Edition
This report focuses on just some of the many factors that hamper the scaling up of DR-TB treatment – the limited availability and high cost of quality-assured medicines for resistant strains of the disease, owing to an insecure market and insufficient demand; and the research questions that remain unsolved with existing medicines.
Last updated 13 November 2012
www.msfaccess.org/content/dr-tb-drugs-under-microscope-2nd-edition -
Out of the Dark: Meeting the Needs of Children With TB
This report will outline the current state of paediatric TB care, looking at current practices, new developments and research needs – in paediatric TB diagnosis, treatment and prevention. It intends to act as a guide to treatment programmes for implementation of the best standard of care currently available to children with TB, and to raise awareness of the need to continue to push for improvements in the management of childhood TB.
Last updated 13 November 2012
www.msfaccess.org/content/out-dark-meeting-needs-of-children-with-TB -
Progress under threat: Perspectives on the HIV treatment gap
While significant gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment and to implement the best science and strategies to fight the disease. The current situation in these five affected countries reminds us that the HIV epidemic is still an emergency in many African countries.
Last updated 28 July 2012
www.msfaccess.org/content/progress-under-threat-perspectives-hiv-treatment-gap -
Closer to Home: Delivering Antiretroviral Therapy in the Community
Experience from Four Countries in Southern Africa
Last updated 25 July 2012
www.msfaccess.org/content/closer-home-delivering-antiretroviral-therapy-community -
Untangling the Web of Antiretroviral Price Reductions: 15th Edition
Eight million people in developing countries are on HIV treatment today, but the number of people who need access to HIV medicines is growing.
Last updated 25 July 2012
www.msfaccess.org/content/untangling-web-antiretroviral-price-reductions-15th-edition -
Speed Up Scale-Up: Strategies, Tools and Policies to Get the Best HIV Treatment to More People, Sooner
Where are we now? For over a decade, people living with HIV, treatment advocates, clinicians, and health ministries have been grappling with how to ensure increased access to quality antiretroviral therapy in resource-limited settings.
Last updated 24 July 2012
www.msfaccess.org/content/speed-scale-strategies-tools-and-policies-get-best-hiv-treatment-more-people-sooner -
Undetectable: How Viral Load Monitoring Can Improve HIV Treatment in Developing Countries
Today, eight million people in developing countries have access to HIV therapy and while many more need to be reached with life-saving medicines, this is important progress. However, the monitoring that goes hand in hand with HIV treatment is still lagging behind in developing countries.
Last updated 23 July 2012
www.msfaccess.org/content/undetectable-how-viral-load-monitoring-can-improve-hiv-treatment-developing-countries
